News Daily News Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients L.A. McKeown January 02, 2024
News Daily News Reduced EF Evident in Some Elite Endurance Athletes Michael O'Riordan December 21, 2023
News Conference News PCR London Valves 2023 Looking for a Winner Between Long-term TAVI Trials? Don’t, Experts Urge Shelley Wood November 27, 2023
News Conference News AHA 2023 Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HM3 Shelley Wood November 11, 2023
News Conference News TCT 2023 Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3 Michael O'Riordan November 01, 2023
News Conference News TCT 2023 SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC Yael L. Maxwell October 30, 2023
News Conference News TCT 2023 VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli L.A. McKeown October 27, 2023
Presentation TCT 2023 Can We Predict RV Failure After Tricuspid Intervention? Presenter: Karl-Philipp Rommel October 26, 2023
Presentation TCT 2023 TCT 778: IASD Implantation Effects on Exercise Capacity and Cardiac Hemodynamics: A Meta-analysis Presenter: Ahmed Elkheshen October 26, 2023
Presentation TCT 2023 Assessing MR Reduction After Transcatheter Edge-to-Edge Repair Imaging and Hemodynamics Presenter: Vratika Agarwal October 25, 2023
Presentation TCT 2023 New Risk Stratification Tools: AI, Biomarkers, Invasive Hemodynamics, etc. Presenter: Amir Darki October 25, 2023
Presentation TCT 2023 Standardized Invasive Hemodynamics to Facilitate Lifetime Patient Management Presenter: James Harvey October 25, 2023
Presentation TCT 2023 Valve Hemodynamics and Device Performance: A New Era in Safety and Technical Success for TAVR in AR Presenter: Raj Makkar October 24, 2023
News Conference News TCT 2023 Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials Michael O'Riordan October 24, 2023